A team of Bloomington-based Indiana University and Philadelphia-based Temple University researchers conducted an analysis to better understand how users are responding to COVID-19 screening chatbots, according to a July 6 study published in the Journal of Informatics in Health and Biomedicine.
The researchers performed an online experiment with 371 participants who viewed a video of a COVID-19 screening session between a hotline agent, either chatbot or human, and a user with mild or severe symptoms.
Results of the analysis showed a slightly negative perception of chatbots’ ability; however, when the perceived ability of the chatbot is the same as a human agent, participants responded more positively to the chatbots.
“When chatbots are perceived to provide the same service quality as human agents, usersare more likely to see them as persuasive, be more satisfied, and be more likely to use them,” the researchers concluded, adding “… to offset users’ biases, a necessary component in deploying chatbots for COVID-19 screening is a strong messaging campaign that emphasizes the chatbot’s ability.”
More articles on digital marketing:
Tallahassee Memorial HealthCare VP discusses new dashboard, rising COVID-19 inpatient population
Smart ideas in health system marketing during the COVID-19 pandemic from 6 execs
Georgia launches campaign to assure citizens about pandemic safety protocols
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
